Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The investigational devices need alterations before validation
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The primary purpose of this investigation is to validate the performance and safety of the Investigational Device (ID) against a validated and legally cleared device for measuring Blood Pressure (BP). The secondary purpose is to validate the performance of the ID over a period of 24 hours against a validated and legally cleared device for Ambulatory Blood Pressure Monitoring (ABPM).
The clinical investigation is conducted as a controlled (subject as own control), prospective, randomised, comparative investigation in a population with a representative spread of BPs to ensure that the ID performs as good as current marketed and approved devices. The study will be conducted in compliance with the International Standard ANSI/AAMI/ISO 81060-2 - Non-invasive sphygmomanometers - Clinical validation of automated measurement type.
This clinical investigation will enrol up to 96 male and female subjects to ensure the recording of 85/35 evaluable datasets in accordance with the ANSI/AAMI/ISO standard [11]. All measurements will be paired and falls into 2 categories: Auscultatory measurements as gold standard reference, oscillometric measurements for clinical practise reference and further validation of ambulatory monitoring and pulse shape measurements.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| ContiPress vs. 3M | Experimental | ContiPress vs. 3M passive and during exercise |
|
| ContiPress vs. Mobil-O-Graph | Experimental | ContiPress vs. Mobil-O-Graph passive, then oscillometric passive, then oscillometric for 24 hrs every 15 mins. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 3M | Device | Conventional measuring of BP |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Accuracy of measurement | The reference measurements are compared with the measurements made by the investigational device | Up to 4 months |
| Measure | Description | Time Frame |
|---|---|---|
| Skin irritation | After removal of each investigational device the skin is assessed. Also participants are instructed to report any skin irritation to investigator | Up to 4 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Breached skin
Acknowledged pregnancy
Pacemaker
Diagnosed cardiac arrhythmia (tachycardia, bradycardia, atrial/ventricular fibrillation)
Implanted metal in upper limb:
Presence of an arterial-venous shunt
Recent axillary node dissection
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Michael H Olsen, Prof. MD | Odense University Hospital | Principal Investigator |
Not provided
Not provided
| ID | Term |
|---|---|
| D006973 | Hypertension |
| D007022 | Hypotension |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ContiPressTM |
| Device |
New way of measuring BP - ContiPressTM Investigational device |
|
| Mobil-O-Graph | Device | 2 different devices for oscillometric measurement of BP |
|